Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Nikken presents new modulator of multidrug resistance

Oct. 24, 1997

New DC-107 derivative presented at cancer meeting

Oct. 24, 1997

New antimitotic agents presented by Kyowa Hakko

Oct. 24, 1997

Improved DNA topoisomerase poisons discovered at Rutgers

Oct. 24, 1997

VEGF inhibitors described by Zeneca

Oct. 24, 1997

Dusa reports positive phase III results for Levulan PDT

Oct. 24, 1997

Preclinical results with L-methioninase presented at cancer meeting

Oct. 23, 1997

Antiproliferative quinazoline derivatives disclosed at Zeneca

Oct. 23, 1997

NeoPharm moves LED to phase I for prostate cancer

Oct. 22, 1997

Pharmacyclics enters into licensing agreement with Nycomed for Lu-Tex

Oct. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...